Pulmonology
Ambrisentan and Tadalafil combination therapy for pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) remains a devastating chronic and progressive disease characterized by elevations in mean pulmonary arterial pressure and pulmonary vascular resistance. It is a complex, progressive disease with several mechanisms, including the endothelin, nitric oxide and prostacyclin pathways with a grave prognosis and a median survival of 2.8 years for untreated patients.
Acute lung injury secondary to nitric acid inhalation: a case series
Nitric Acid is a strong oxidizing agent used in industrial factories to dissolve metals and ingredients for organic compounds. Once inhaled, it is highly corrosive to the respiratory tract.
Acute lung injury secondary to nitric acid inhalation: a case series
Nitric Acid is a strong oxidizing agent used in industrial factories to dissolve metals and ingredients for organic compounds. Once inhaled, it is highly corrosive to the respiratory tract.
Ambrisentan and Tadalafil combination therapy for pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) remains a devastating chronic and progressive disease characterized by elevations in mean pulmonary arterial pressure and pulmonary vascular resistance. It is a complex, progressive disease with several mechanisms, including the endothelin, nitric oxide and prostacyclin pathways with a grave prognosis and a median survival of 2.8 years for untreated patients.